Clinical Trials
60 trialsBio-lung
University Hospital, Lille
ECP
Centre Chirurgical Marie Lannelongue
LUNG-RESIST
University Hospital, Toulouse
KOBE
University Hospital, Toulouse
OPTALK
Groupe Francais De Pneumo-Cancerologie
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Vanderbilt-Ingram Cancer Center
Circulating Tumor Cells (CTC) in Lung Cancer
Indiana University
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
RICEPS-2
University Hospital, Tours
PneumoTAV001
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer
The Netherlands Cancer Institute
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
The Institute of Molecular and Translational Medicine, Czech Republic
B-GLUCANCER2
Poitiers University Hospital
BREATHE
Nantes University Hospital
ULYSSE
Hospices Civils de Lyon
RESISTYR
Rennes University Hospital
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
Hasselt University
BCBPoumon
Institut du Cancer de Montpellier - Val d'Aurelle
IPON-3
Maastricht Radiation Oncology
PROGRESS
UNC Lineberger Comprehensive Cancer Center
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Stanford University
A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine
University of Arkansas
Genetic Susceptibility to Lung Cancer in Never Smokers
Memorial Sloan Kettering Cancer Center
EXODIAG
Centre Georges Francois Leclerc
UMBRELLA
Gustave Roussy, Cancer Campus, Grand Paris
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
EGFR Lung Canc
Our Lady of the Lake Hospital
FUTURE
Assistance Publique Hopitaux De Marseille
Lymphocyte Depletion and Change in Lymphocyte Functionality
University of Virginia
CANTO
UNICANCER
ARIA
Scientific Institute San Raffaele
BIOCEPTION
Assistance Publique Hopitaux De Marseille
PREVALUNG*
Assistance Publique Hopitaux De Marseille
RICEPS
University Hospital, Tours
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
Cedars-Sinai Medical Center
HEPATICI
Centre Hospitalier Universitaire, Amiens
Evolution of the Heart Function When Monitoring Immunotherapies Anti-cancerous Inhibiting PD-1
Assistance Publique Hopitaux De Marseille
DNA Repair and Genetic Susceptibility to Lung Cancer
Memorial Sloan Kettering Cancer Center
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
'Lung Health Check' Biomarker Study
Royal Marsden NHS Foundation Trust
LUN0017
Stanford University
DECAMP-1
Boston University
GOLF
Royal Marsden NHS Foundation Trust
ONCOPRO
Hospices Civils de Lyon
A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer
Abramson Cancer Center at Penn Medicine
Personalizing Immune Checkpoint Inhibitor Therapy
Holy Cross Hospital, Maryland
ECTOPIC/MUTAS
University Hospital, Grenoble
POIR
Centre Hospitalier Universitaire de Saint Etienne
ALCAPONE
Centre Georges Francois Leclerc